Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT02535273
Other study ID # Tangdu-dex-loc
Secondary ID
Status Not yet recruiting
Phase Phase 4
First received August 20, 2015
Last updated August 25, 2015
Start date September 2015
Est. completion date September 2016

Study information

Verified date August 2015
Source Tang-Du Hospital
Contact n/a
Is FDA regulated No
Health authority China: Food and Drug Administration
Study type Interventional

Clinical Trial Summary

Evaluate safety and efficacy of dexmedetomidine in minimally invasive spine surgery under local anesthesia sedation.Explore the appropriate concentration of dexmedetomidine, whether or not can reduce the amount of local anesthetics.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 212
Est. completion date September 2016
Est. primary completion date August 2016
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Sign the informed consent;

- American Society of Anesthesiologists (ASA)classification:class I~II;Elective minimally invasive spine surgery;

- Age =18 years old, weighing 45 ~ 80 Kg, height 151 ~ 185 cm;

- hypertension within ? grade, or controlled with drugs within ? level;

- Diabetes fasting in 8.3mol/L or less

Exclusion Criteria:

- DEX allergy;

- Change anesthesia preoperative or intraoperative ;

- metabolic disorders, anemia has not been corrected;

- recent patients receiving sedatives and antidepressants;

- degenerative diseases of the central nervous elderly persons;

- serious central nervous system diseases (acute stroke, uncontrolled epilepsy, severe dementia);

- hypovolemia; 8) unstable angina or acute myocardial infarction;

- left ventricular ejection fraction less than 30%, heart rate lower than 45bpm;

- II-III degree heart block;

- acute hepatitis or severe liver disease (liver function C level);

- patients with renal insufficiency randomly assigned to receive treatment, but If patients need dialysis test is excluded or interruption ;

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Investigator, Outcomes Assessor), Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Drug:
Dexmedetomidine
load dosage:Intravenous injection dexmedetomidine 1 µg/kg,completed within 10 minutes.
Lidocaine
local anesthesia:0.67% lidocaine local anesthesia layer by layer to the periosteum at the puncture site,Establish puncture channel, injection 5ml 0.67% lidocaine into the vertebral body through the catheter, and observe 5-10min before operation
Low-dose Dexmedetomidine
maintenance dose:Intravenous infusion of dexmedetomidine 0.3 µg/kg/min until the end of surgery
Moderate-dose Dexmedetomidine
maintenance dose:Intravenous infusion of dexmedetomidine 0.5 µg/kg/min until the end of surgery
High-dose Dexmedetomidine
maintenance dose:Intravenous infusion of dexmedetomidine 0.7 µg/kg/min until the end of surgery
normal saline
Intravenous injection normal saline equal quantity,completed within 10 minutes. Intravenous infusion of normal saline 0.125 µg/kg/min until the end of surgery

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Tang-Du Hospital

References & Publications (5)

Arts MP. Reply to the letter to the editor of R. Q. Knight concerning "does minimally invasive lumbar disc surgery result in less muscle injury than conventional surgery? A randomized controlled trial" by M. Arts, R. Brand, et al. (2011) Eur Spine J 20(1):51-57. doi:10.1007/s00586-012-2491-9. Eur Spine J. 2013 Apr;22(4):899. doi: 10.1007/s00586-012-2643-y. Epub 2013 Jan 9. — View Citation

Gandhi SD, Anderson DG. Minimally invasive surgery for the lumbar spine. J Neurosurg Sci. 2012 Mar;56(1):27-34. Review. — View Citation

Nakamura Y, Yabuki S, Kikuchi S, Konno S. Minimally invasive surgery for osteoid osteoma of the cervical spine using microendoscopic discectomy system. Asian Spine J. 2013 Jun;7(2):143-7. doi: 10.4184/asj.2013.7.2.143. Epub 2013 May 22. — View Citation

Smith N, Masters J, Jensen C, Khan A, Sprowson A. Systematic review of microendoscopic discectomy for lumbar disc herniation. Eur Spine J. 2013 Nov;22(11):2458-65. doi: 10.1007/s00586-013-2848-8. Epub 2013 Jun 23. Review. — View Citation

Yoshimoto M, Takebayashi T, Ida K, Tanimoto K, Yamashita T. Microendoscopic discectomy in athletes. J Orthop Sci. 2013 Nov;18(6):902-8. doi: 10.1007/s00776-013-0442-x. Epub 2013 Jul 20. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Ramsay sedation score Evaluation time point:1min before dexmedetomidine infusion;1min before local anesthesia;lidocaine infiltrate layer by layer to the periosteum,assessed up to 2min;Intraoperative most painful moments,assessed up to 5min;1min before returning to the ward;2h after surgery.Intraoperative most painful moments:nucleus pulpous probe or Balloon Dilatation. From 1min before dexmedetomidine infusion to 2h after surgery,up to 4 hours Yes
Primary visual analogue scale Evaluation time point:1min before dexmedetomidine infusion;1min before local anesthesia;lidocaine infiltrate layer by layer to the periosteum,assessed up to 2min;Intraoperative most painful moments,assessed up to 5min;1min before returning to the ward;2h after surgery.Intraoperative most painful moments:nucleus pulpous probe or Balloon Dilatation. From 1min before dexmedetomidine infusion to 2h after surgery,up to 4 hours Yes
Secondary The total amount of lidocaine 2h after surgery; Yes
Secondary The patient and the surgeon satisfaction four grades:Very satisfied; General satisfied; Not satisfied; Very dissatisfied 2h after surgery; Yes
See also
  Status Clinical Trial Phase
Completed NCT04633850 - Implementation of Adjuvants in Intercostal Nerve Blockades for Thoracoscopic Surgery in Pulmonary Cancer Patients
Completed NCT03262857 - Effect of Lidocaine With Magnesium Sulfate on the Success of the Inferior Alveolar Nerve Block Phase 2
Withdrawn NCT03502135 - Efficacy of Tetracaine/Oxymetazoline Nasal Spray for Endodontic Treatment Phase 4
Not yet recruiting NCT05902780 - Can Caudal Dexmedetomidine Provide Effective Analgesia? N/A
Completed NCT04885777 - Topical Lidocaine Anesthesia for Nasopharyngeal Sampling N/A
Recruiting NCT04086394 - PECS Block in Partial Mastectomy for Postoperative Pain Control N/A
Recruiting NCT06129162 - Pain Perception Comparison of Computerized vs Conventional Injection Methods N/A
Completed NCT02922504 - Impact of Music Intervention on Pain Control In First Trimester Surgical Abortion Under Local Anesthesia N/A
Completed NCT00539084 - A Study to Assess the Safety and Efficacy of a Microneedle Device for Local Anesthesia N/A
Completed NCT03176446 - Pain and Anxiety Evaluation in Children Using Different Techniques of Local Anesthesia for Dental Treatment N/A
Completed NCT04947267 - To Compare the Pulpal Oxygen Saturation Level After Administering Mepivacaine With and Without Vasoconstrictor Phase 2
Completed NCT02825225 - A Prospective Randomized Trial of Two Different Prostate Biopsy Schemes N/A
Completed NCT01360749 - Efficacy and Safety of Lambdalina (Lidocaine Cream) Versus Placebo as an Anesthetic for Laser Hair Removal Phase 2
Completed NCT00889642 - Safety and Efficacy Study of an Iontophoretic Patch Containing Lidocaine and Epinephrine for Venipuncture in Healthy Adult Volunteers Phase 2
Not yet recruiting NCT06395987 - Result Of Use Of Wide Awake Local Anaesthesia In Fixation Of Ankle Fractures
Active, not recruiting NCT05473819 - Effectiveness of Sodium Bicarbonate Buffered Anaesthetic Solution on Pain During Injection N/A
Completed NCT04653974 - Pain Perception of Needle-free System N/A
Completed NCT02884596 - Success of Inferior Alveolar Nerve Block in Women Taking Selective Serotonin Reuptake Inhibitors
Completed NCT02440347 - Effects of Articaine Computer-controlled and Conventional Delivery for Anterior and Middle Superior Alveolar Nerve Block Phase 4
Completed NCT02371759 - Lidocaine + Clonidine for Intraoral Anesthesia in Patients With Diabetes Mellitus Type 2 Phase 3